Tailoring Treatment of EGFR-Mutated NSCLC to Improve Patient Care, Oct 24

Start Date : October 24, 2018
End Date : October 24, 2018
Time : 6:00 pm to8:00 pm

Phone : 866-690-9902
Email : registration@clinicaloptions.com

Location :
Orlando World Center Marriott,8701 World Center Drive,Canary 1-2, Orlando, 32821, USA



Join us on Wednesday, October 24 at the Orlando World Center Marriott for this interactive symposium where pharmacy and oncology experts Val R. Adams, PharmD, FCCP, BCOP; Edward S. Kim, MD, FACP; and Philip Schwieterman, PharmD, MHA, provide their perspectives on the role of EGFR-targeted therapies in the management of patients with advanced EGFR-mutated NSCLC, including insights into the latest first-line and second-line clinical data and how pharmacists can safely and effectively apply these new practice-changing data into care plans for their patients. 

This satellite symposium is complimentary to attend and is ACPE-certified for 1.5 contact hours. For more information and to register, visit our site here: https://events.clinicaloptions.com/oncology/Nexus2018. 


Speakers: Val R. Adams, PharmD, FCCP, BCOP, Edward S. Kim, MD, FACP, Philip Schwieterman, PharmD, MHA

Organized by

Organized by LoveEvvnt1

CCO Registration

Email: registration@clinicaloptions.com

Event Categories: Health & Nutrition.

Your Review

You must be logged in to post a comment.